Stock Research: Novo Nordisk

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

What's New

Recent improvements to enhance your investment research experience

360° View free for everyone

Our most comprehensive analysis—the 360° View—is now free for everyone. To maintain our research quality, other ranks are now part of our new subscription plans.

3 new subscription models

Plans for every investor - from stock ideas to in-depth analysis.

Similar Stocks

Four stock alternatives to the stock you're searching.

Novo Nordisk

CPSE:NOVO B DK0060534915
1
  • Value
    27
  • Growth
    7
  • Safety
    Safety
    37
  • Combined
    1
  • Sentiment
    7
  • 360° View
    360° View
    1
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Novo Nordisk A/S is a global healthcare company specializing in diabetes care, and the development, manufacturing, and marketing of pharmaceutical products. It operates in the diabetes and obesity care, and biopharmaceuticals industries, with products like NovoLog/NovoRapid and NovoSeven. The company markets its products in over 180 countries, with commercial units in North America and International Operations. In the last fiscal year, the company had a market cap of $300970 million, profits of $34273 million, and revenue of $40321 million, with 76302 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 1 (better than 1% compared with alternatives), overall professional sentiment and financial characteristics for the stock Novo Nordisk are critical, mostly below average. The 360° View is based on consolidating four consolidated indicators, with all four indicators below average for Novo Nordisk. The consolidated Value Rank has a low rank of 37 which means that the share price of Novo Nordisk is on the higher side compared with typical size in indicators such as revenues, profits, and invested capital. This means the stock price is higher than for 63% of alternative stocks in the same industry. The consolidated Growth Rank also has a low rank of 7, which means that the company exhibits below-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. This means that growth is lower than for 7% of competitors in the same industry. The consolidated Safety Rank has a riskier rank of 27, which means that the company has a riskier financing structure than 73% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. Finally, the consolidated Sentiment Rank has a low rank of 7, which means that professional investors are more pessimistic about the stock than for 93% of alternative investment opportunities. ...read more

more
Index
OMX C20
Employee Focus EU
Human Rights
Low Waste
Recycling
SDG 11
SDG 12
SDG 13
SDG 17
SDG 3
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 21-Aug-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
37 12 9 12
Growth
7 42 99 69
Safety
Safety
27 26 48 68
Sentiment
7 34 30 8
360° View
360° View
1 7 37 26
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
24 42 28 9
Opinions Change
12 31 52 34
Pro Holdings
n/a 87 82 74
Market Pulse
29 24 15 17
Sentiment
7 34 30 8
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
37 12 9 12
Growth
7 42 99 69
Safety Safety
27 26 48 68
Combined
1 7 54 48
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
54 14 11 17
Price vs. Earnings (P/E)
19 7 7 13
Price vs. Book (P/B)
1 1 1 1
Dividend Yield
88 68 61 61
Value
37 12 9 12
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
53 89 79 61
Profit Growth
50 65 84 54
Capital Growth
9 16 82 29
Stock Returns
1 12 94 92
Growth
7 42 99 69
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
16 25 52 65
Refinancing
3 6 11 12
Liquidity
92 86 85 85
Safety Safety
27 26 48 68

Similar Stocks

Discover high‑ranked alternatives to Novo Nordisk and broaden your portfolio horizons.

thyssenkrupp

XTRA:TKA
Country: Germany
Industry: Steel
Size: X-Large
Full Stock Analysis

Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt.

BUSE:RICHTER
Country: Hungary
Industry: Pharmaceuticals
Size: Medium
Full Stock Analysis

Polski Koncern Naftowy ORLEN Spolka Akcyjna

WSE:PKN
Country: Poland
Industry: Oil & Gas Refining
Size: X-Large
Full Stock Analysis

Infineon

XTRA:IFX
Country: Germany
Industry: Semiconductors
Size: X-Large
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.